tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RANI Stock Latest News

Rani Therapeutics management to meet virtually with BTIG
The FlyRani Therapeutics management to meet virtually with BTIG
3d ago
RANI
Rani Therapeutics price target lowered to $9 from $21 at Canaccord
PremiumThe Fly
Rani Therapeutics price target lowered to $9 from $21 at Canaccord
29d ago
RANI
Rani Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
PremiumThe Fly
Rani Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
1M ago
RANI
Rani Therapeutics reports Q4 EPS (27c), consensus (31c)
PremiumThe Fly
Rani Therapeutics reports Q4 EPS (27c), consensus (31c)
1M ago
RANI
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
PremiumPress Releases
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
1M ago
RANI
RANI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsRANI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
RANI
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
1M ago
RANI
Rani Therapeutics Reports Positive Phase 1 Trial Outcomes
PremiumCompany Announcements
Rani Therapeutics Reports Positive Phase 1 Trial Outcomes
3M ago
8K
RANI
Rani Therapeutics Shares Exciting Clinical Trial Results
PremiumCompany Announcements
Rani Therapeutics Shares Exciting Clinical Trial Results
3M ago
8K
RANI
Rani Therapeutics announces topline results from Phase 1 study of RT-111
PremiumThe Fly
Rani Therapeutics announces topline results from Phase 1 study of RT-111
3M ago
RANI
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
PremiumPress Releases
Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
4M ago
RANI
Rani Therapeutics announces preliminary pharmacodynamic data on GLP-1
PremiumThe Fly
Rani Therapeutics announces preliminary pharmacodynamic data on GLP-1
4M ago
RANI
Rani Therapeutics reports Q3 EPS (36), consensus (37c)
PremiumThe FlyRani Therapeutics reports Q3 EPS (36), consensus (37c)
6M ago
RANI
Rani Therapeutics price target lowered to $7 from $24 at BTIG
PremiumThe Fly
Rani Therapeutics price target lowered to $7 from $24 at BTIG
6M ago
RANI
Rani Therapeutics price target lowered to $21 from $26 at Canaccord
PremiumThe Fly
Rani Therapeutics price target lowered to $21 from $26 at Canaccord
6M ago
RANI
Rani Therapeutics price target lowered to $16 from $20 at H.C. Wainwright
PremiumThe Fly
Rani Therapeutics price target lowered to $16 from $20 at H.C. Wainwright
6M ago
RANI
Rani Therapeutics announces development of RT-101 cancelled, 25% workforce cut
PremiumThe Fly
Rani Therapeutics announces development of RT-101 cancelled, 25% workforce cut
6M ago
RANI
Rani Therapeutics sees Q3 net loss $17M -$19M
PremiumThe Fly
Rani Therapeutics sees Q3 net loss $17M -$19M
6M ago
RANI
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
PremiumPress Releases
Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
6M ago
RANI
Rani Therapeutics sees Q3 net loss $17M-$19M vs $16.2M last year
PremiumThe FlyRani Therapeutics sees Q3 net loss $17M-$19M vs $16.2M last year
6M ago
RANI
Rani Therapeutics announces preclinical data on RaniPill platform
PremiumThe Fly
Rani Therapeutics announces preclinical data on RaniPill platform
6M ago
RANI
Rani announces oral delivery of monoclonal antibody via high-capacity pill
PremiumThe Fly
Rani announces oral delivery of monoclonal antibody via high-capacity pill
6M ago
RANI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >